Monosodium Glutamate (MSG) markets in the Asia-Pacific region saw continued softness in August, driven by strategic supplier pricing and ample inventory levels. Manufacturers benefited from lower corn starch costs, improving access to glutamic acid and reducing production expenses. Buyers had already stocked up in July, anticipating seasonal and regulatory shifts, which eased procurement pressure. Demand from food and pharmaceutical sectors remained cautious. ChemAnalyst predicts stable market conditions ahead, urging stakeholders to monitor global trade dynamics and adopt flexible procurement strategies to navigate evolving trends and maintain competitiveness.
The prices of Monosodium Glutamate (MSG) in the Asia-Pacific region have continued to show downward trajectory till the third week of August. The prices of pharmaceutical-grade market of MSG were in downtrend which was driven by multiple factors. The suppliers have adopted strategic pricing to reflect reduced production costs. The buyers have leaned on well-maintained inventories that was built during the previous month’s procurement cycle which marked the beginning of Qx xxxx. The procurement specialists had already placed bulk orders to align the inventories with the seasonal demand anticipation and new production cycles. Maintained inventory levels have resulted in subdued urgency in August which further reinforced the price dip. The declining cost of corn starch has enabled MSG formulators with easier access to glutamic acid that resulted in a decline in MSG production costs.
The MSG market in August was shaped...
